Showing 1881-1900 of 7110 for: Cochrane Systematic Reviews Back
- Drug treatment for spinal muscular atrophy type I
Cochrane Systematic Reviews, 13-Mar-2012
Spinal muscular atrophy (SMA) is caused by degeneration of anterior horn cells of the spinal cord, which leads to progressive muscle weakness. Children with SMA type I will never be able to sit without support and usually die by the age of two years. Ther
- Drug treatment for spinal muscular atrophy types II and III
Cochrane Systematic Reviews, 13-Mar-2012
Spinal muscular atrophy (SMA) is caused by degeneration of anterior horn cells, which leads to progressive muscle weakness. Children with SMA type II do not develop the ability to walk without support and have a shortened life expectancy, whereas children
- Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
Cochrane Systematic Reviews, 20-Oct-2015
Coronary artery stents are tiny tubular devices used to 'scaffold' vessels open during percutaneous transluminal coronary angioplasty (PTCA). Restenosis (re-narrowing) of vessels treated with stents is a problem; in order to reduce restenosis, stents that
- Drugs and pacemakers for vasovagal, carotid sinus and situational syncope
Cochrane Systematic Reviews, 9-Apr-2013
Neurally mediated reflex syncope is the most common cause of transient loss of consciousness. In patients not responding to non-pharmacological treatment, pharmacological or pacemaker treatment might be considered.
- Drugs for discoid lupus erythematosus
Cochrane Systematic Reviews, 11-Aug-2009
Discoid lupus erythematosus is a chronic form of cutaneous (skin) lupus which can cause permanent scarring if treatment is inadequate. Many drugs have been used to treat this disease and some of these are potentially very toxic.
- Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)
Cochrane Systematic Reviews, 24-Oct-2012
Enuresis (bedwetting) is a socially stigmatising and stressful condition which affects around 15% to 20% of five-year olds and up to 2% of young adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological costs
- Drugs for preventing lung cancer in healthy people
Cochrane Systematic Reviews, 6-Sep-2012
This is an updated version of the original review published in Issue 2, 2003. Some studies have suggested a protective effect of antioxidant nutrients on lung cancer. Observational epidemiological studies suggest an association between higher dietary leve
- Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment
Cochrane Systematic Reviews, 3-Oct-2014
Pregnancy increases the risk of malaria and this is associated with poor health outcomes for both the mother and the infant, especially during the first or second pregnancy. To reduce these effects, the World Health Organization recommends that pregnant w
- Drugs for preventing malaria in travellers
Cochrane Systematic Reviews, 1-Oct-2015
Malaria infects 10,000 to 30,000 international travellers each year. It can be prevented through anti-mosquito measures and drug prophylaxis. However, antimalaria drugs have adverse effects which are sometimes serious.
- Drugs for preventing migraine headaches in children
Cochrane Systematic Reviews, 11-Jul-2014
It has been estimated that about 10 per cent of children between 6 and 20 years of age suffer from migraine, and that children with migraine lose one and a half weeks more schooling per year than their peers. Prophylactic drugs can be prescribed when chil
- Drugs for preventing postoperative nausea and vomiting
Cochrane Systematic Reviews, 5-Mar-2014
Drugs can prevent postoperative nausea and vomiting, but their relative efficacies and side effects have not been compared within one systematic review.
- Drugs for preventing red blood cell dehydration in people with sickle cell disease
Cochrane Systematic Reviews, 4-Mar-2016
Sickle cell disease is an inherited disorder of hemoglobin, resulting in abnormal red blood cells. These are rigid and may block blood vessels leading to acute painful crises and other complications. Recent research has focused on therapies to rehydrate t
- Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis
Cochrane Systematic Reviews, 11-May-2009
The emergence and spread of multiple-drug-resistant tuberculosis (MDR-TB), caused by strains of Mycobacterium tuberculosis resistant to at least isoniazid and rifampicin, is a potential threat to global tuberculosis control. Treatment is prolonged, expens
- Drugs for the treatment of nausea and vomiting in adults in the emergency department setting
Cochrane Systematic Reviews, 28-Sep-2015
Nausea and vomiting is a common and distressing presenting complaint in emergency departments (ED). The aetiology of nausea and vomiting in EDs is diverse and drugs are commonly prescribed. There is currently no consensus as to the optimum drug treatment
- Drugs for treating giardiasis
Cochrane Systematic Reviews, 13-Nov-2008
There can be a high rate of recurrence of disease after initial drug treatment for giardiasis. These drugs also have a range of adverse effects.
- Drugs for treating giardiasis
Cochrane Systematic Reviews, 12-Nov-2012
Giardiasis infection may be asymptomatic, or can cause diarrhoea (sometimes severe), weight loss, malabsorption, and, in children, failure to thrive. It is usually treated with metronidazole given three times daily for five to 10 days.
- Drugs for treating paracoccidioidomycosis
Cochrane Systematic Reviews, 30-Jun-2011
Paracoccidioidomycosis is a fungal infection that occurs only in some particular places in Latin America. Treatment is long, the drugs have side effects, and patients can relapse. However, the disease is potentially fatal.
- Drugs for treating Schistosoma mansoni infection
Cochrane Systematic Reviews, 29-Jan-2013
Schistosoma mansoni is a parasitic infection common in the tropics and sub-tropics. Chronic and advanced disease includes abdominal pain, diarrhoea, blood in the stool, liver cirrhosis, portal hypertension, and premature death.
- Drugs for treating uncomplicated malaria in pregnant women
Cochrane Systematic Reviews, 11-Aug-2008
Women are more vulnerable to malaria during pregnancy, and malaria infection may have adverse consequences for the fetus. Identifying safe and effective treatments is important.
- Drugs for treating urinary schistosomiasis
Cochrane Systematic Reviews, 7-Jul-2014
Urinary schistosomiasis is caused by an intravascular infection with parasitic Schistosoma haematobium worms. The adult worms typically migrate to the venous plexus of the human bladder and excrete eggs which the infected person passes in their urine. Chr
